Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Research Site, Tucson, Arizona Research Site, Stanford, California Research Site, Chicago, Illinois Research Site, Ann Arbor, Michigan Research Site, St Louis, Missouri Research Site, New York, New York Research Site, Chapel Hill, North Carolina Research Site, Seattle, Washington Australia
Research Site, Darlinghurst Germany
Research Site, Mainz Am Rhein